Lung Function in Patients Receiving BusulphanBr Med J 1970; 4 doi: https://doi.org/10.1136/bmj.4.5734.530 (Published 28 November 1970) Cite this as: Br Med J 1970;4:530
- W. A. Littler,
- Colin Ogilvie
An attempt was made to achieve earlier detection of busulphan lung (fibrosing alveolitis) and to determine its incidence by means of serial studies during life, including measurement of the gas transfer factor. Twenty-three patients were investigated over an average period of nearly two years of busulphan treatment. One case of busulphan lung was detected and subsequently confirmed at necropsy, but in the remainder there was no clinical, radiological, or physiological evidence of fibrosing alveolitis. It is concluded that the development of fibrosing alveolitis may be related to individual genetic or immunological factors rather than to busulphan dosage.